Notes
to the Financial Statements
December
31, 2020 and 2019
NOTE
1 - NATURE OF BUSINESS
Quarta-Rad,
Inc. (the “Company”) was incorporated under the laws of the state of Delaware on November 29, 2011, under the name
Quatra-Rad, Inc. and amended its Certificate of Incorporation on February 29, 2012 to change its name to Quarta-Rad, Inc. On July
2, 2012, the Company amended and restated its Certificate of Incorporation to increase its authorized shares of common stock to
50,000,000, $0.0001 par value from 1,500, no par value and effected a 10,000 to 1 forward split. The Company distributes detection
devices, including but not limited to Geiger counters, to homeowners and interested customers in North America, Europe, and Asia.
The Company targets homebuilders and home renovation contractors.
During
April 2020, the Company acquired Quarta-Rad USA, Inc., a Delaware corporation, as a wholly owned subsidiary. There was no consideration
paid for the shares. The purpose of the acquisition is to separate the sales of certain products in separate entities. There was
no activity, assets or liabilities in the subsidiary through December 31, 2020.
During
December 2020, the Company acquired Sellavir, Inc., a Delaware. corporation, as a wholly owned subsidiary, as discussed in Note
7. Sellavir is a video analytics company whose platform empowers organizations to decode videos to develop creative marketing
strategies and analysis through advanced and proprietary technologies.
NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis
of Presentation
These
financial statements and related notes are presented in accordance with accounting principles generally accepted in the United
States and are expressed in United States (US) dollar. The Company’s financial statements are prepared using the accrual
method of accounting. The Company has elected a December 31 fiscal year end.
Principles
of Consolidation
The
consolidated financial statements include the accounts Quarta-Rad, Inc. and its wholly-owned subsidiaries Quarta-Rad USA, Inc.
and Sellavir, Inc. All significant intercompany balances and transactions have been eliminated in consolidation.
Cash
and Cash Equivalents
The
Company considers all highly liquid investments with maturity of three months or less when purchased to be cash equivalents. The
Company does not have any cash equivalents as of December 31, 2020 and 2019.
Use
of Estimates and Assumptions
The
preparation of financial statements in conformity with accounting principles generally accepted in the United States (“U.S.
GAAP”) requires management to make estimates and judgments that affect the reported amounts of assets, liabilities and disclosure
of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during
the reporting periods.
Significant
estimates made by management include, among others, provisions for the valuation of accounts receivable, accrual of European VAT
reserve, and the recoverability of inventory. The Company bases its estimates on historical experience, knowledge of current conditions
and belief of what could occur in the future considering available information. The Company reviews its estimates on an on-going
basis. The actual results experienced by the Company may differ materially and adversely from its estimates. To the extent there
are material differences between the estimates and actual results, future results of operations will be affected.
Advertising
The
Company expenses advertising costs, consisting primarily of placement in multiple publications, along with design and printing
costs of sales materials, when incurred. Advertising expense for the years ended December 31, 2020 and 2019 amounted to $63,122
and $47,624, respectively.
Property
and Equipment
Property
and equipment are stated at cost. Depreciation is provided on the straight-line method over the estimated useful lives of the
related assets, which is five years. Leasehold improvements are amortized over the shorter of their estimated useful lives or
their related lease terms. Repairs and maintenance costs are charged to expense when incurred.
Long-Lived
Assets
The
Company reviews the carrying values of its long-lived assets for possible impairment whenever events or changes in circumstances
indicate that the carrying amount may not be recoverable. If the expected future cash flow from the use of the asset and its eventual
disposition is less than the carrying amount of the asset, an impairment loss is recognized and measured using the fair value
of the related asset. No impairment charges were incurred during the years ended December 31, 2020 and 2019. There can be no assurance,
however, that market conditions will not change or demand for the Company’s services will continue, which could result in
impairment of long-lived assets in the future.
Income
Taxes
The
Company uses the asset and liability method of accounting for income taxes in accordance with ASC 740-10, “Accounting for
Income Taxes.” Under this method, income tax expense is recognized for the amount of: (i) taxes payable or refundable for
the current year; and, (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized
in an entity’s financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates
expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.
The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period
that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if, based on the
weight of available positive and negative evidence, it is more likely than not that some portion or all of the deferred tax assets
will not be realized.
ASC
740-10 prescribes a recognition threshold and measurement attribute for the financial statement recognition of a tax position
taken or expected to be taken on a tax return. Under ASC 740-10, a tax benefit from an uncertain tax position taken or expected
to be taken may be recognized only if it is “more likely than not” that the position is sustainable upon examination,
based on its technical merits. The tax benefit of a qualifying position under ASC 740-10 would equal the largest amount of tax
benefit that is greater than 50% likely of being realized upon ultimate settlement with a taxing authority having full knowledge
of all the relevant information. A liability (including interest and penalties, if applicable) is established to the extent a
current benefit has been recognized on a tax return for matters that are considered contingent upon the outcome of an uncertain
tax position. Related interest and penalties, if any, are included as components of income tax expense and income taxes payable.
As
of December 31, 2020, we have analyzed filing positions in each of the federal and state jurisdictions where we are required to
file income tax returns, as well as all open tax years in these jurisdictions. We have identified the U.S. federal and Delaware
as our “major” tax jurisdictions. Generally, we remain subject to Internal Revenue Service examination of our 2017
through 2020 tax returns. However, we have certain tax attribute carry forwards, which will remain subject to review and adjustment
by the relevant tax authorities until the statute of limitations closes with respect to the year in which such attributes are
utilized.
We
believe that our income tax filing positions and deductions will be sustained on audit and do not anticipate any adjustments that
will result in a material change to our financial position. Therefore, no reserves for uncertain income tax position have been
recorded pursuant to ASC 740. In addition, we did not record a cumulative effect adjustment related to the adoption of ASC 740.
Related interest and penalties, if any, are included as components of income tax expense and income taxes payable.
Inventory
Accounting Policy
Inventories
are stated at the lower of cost or market (net realizable value). The Company periodically reviews the value of items in inventory
and provides write-downs or write-offs of inventory based on its assessment of market conditions. Write-downs and write-offs are
charged to cost of goods sold. The Company’s inventory consists entirely of finished goods available for sale.
Earnings
per Share
The
Company’s basic earnings per share are calculated by dividing its net income available to common stockholders by the weighted
average number of common shares outstanding for the period. The Company’s dilutive earnings per share is calculated by dividing
its net income available to common shareholders by the diluted weighted average number of shares outstanding during the period.
The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially
dilutive debt or equity.
Fair
Value of Financial Instruments
The
Company’s financial instruments as defined by ASC 825, “Financial Instruments” include cash, trade accounts
receivable, and accounts payable and accrued expenses. All instruments are accounted for on a historical cost basis, which, due
to the short maturity of these financial instruments, approximates fair value at December 31, 2020 and 2019.
FASB
ASC 820 “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring
fair value in accordance with generally accepted accounting principles, and expands disclosures about fair value measurements.
ASC 820 establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:
|
●
|
Level
1. Observable inputs such as quoted prices in active markets;
|
|
|
|
|
●
|
Level
2. Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
|
|
|
|
|
●
|
Level
3. Unobservable inputs in which there is little or no market data, which requires the reporting entity to develop its own
assumptions.
|
Revenue
Recognition
We adopted FASB Accounting Standards
Codification ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). The guidance sets forth
a five-step revenue recognition model which replaces the prior revenue recognition guidance in its entirety and is intended to
eliminate numerous industry-specific pieces of revenue recognition guidance that have historically existed in U.S. GAAP. The underlying
principle of the standard is that a business or other organization will recognize revenue to depict the transfer of promised goods
or services to customers in an amount that reflects what it expects to receive in exchange for the goods or services.
Our
principal activities from which we generate our revenue are product sales and consulting services.
Revenue
is measured based on consideration specified in a contract with a customer. A contract with a customer exists when we enter into
an enforceable contract with a customer. The contract is based on either the acceptance of standard terms and conditions on the
websites for e-commerce customers and via telephone with our third-party call center for our print media and direct mail customers,
or the execution of terms and conditions contracts with retailers and wholesalers. These contracts define each party’s rights,
payment terms and other contractual terms and conditions of the sale. Consideration is typically paid prior to shipment via credit
card or check when our products are sold direct to consumers or approximately 30 days from the time control is transferred when
sold to wholesalers, distributors and retailers. We apply judgment in determining the customer’s ability and intention to
pay, which is based on a variety of factors including the customer’s historical payment experience and, in some circumstances,
published credit and financial information pertaining to the customer.
A
performance obligation is a promise in a contract to transfer a distinct product to the customer. Performance obligations promised
in a contract are identified based on the goods that will be transferred to the customer that are both capable of being distinct
and are distinct in the context of the contract, whereby the transfer of the goods is separately identifiable from other promises
in the contract. We have concluded the sale of goods and related shipping and handling are accounted for as the single performance
obligation.
The
transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as the
customer receives the benefit of the performance obligation. The transaction price is determined based on the consideration to
which we will be entitled to receive in exchange for transferring goods to the customer. We issue refunds to e-commerce and print
media customers, upon request, within 30 days of delivery. We estimate the amount of potential refunds at each reporting period
using a portfolio approach of historical data, adjusted for changes in expected customer experience, including seasonality and
changes in economic factors. For retailers, distributors and wholesalers, we do not offer a right of return or refund and revenue
is recognized at the time products are shipped to customers. In all cases, judgment is required in estimating these reserves.
Actual claims for returns could be materially different from the estimates. There was no reserve for sales returns and allowances,
at December 31, 2020 and December 31, 2019, respectively.
We
recognize revenue when we satisfy a performance obligation in a contract by transferring control over a product to a customer
when product is shipped. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing
transaction, that are collected by us from a customer, are excluded from revenue. Shipping and handling costs associated with
outbound freight after control over a product has transferred to a customer are accounted for as a fulfillment cost and are included
in cost of product sales.
We
recognize consulting revenue over times as services are performed.
Recent
Accounting Pronouncements
In
December 2019, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2019-12 Simplifying
the Accounting for Income Taxes. Effective for public entities for fiscal years beginning after December 15, 2020. The ASU
is intended to simplify aspects of accounting for income taxes, including deferred taxes on investments, and calculation of taxes
in interim periods. The adoption of this guidance by the Company did not have a material impact on its financial statements and
related disclosures.
NOTE
3–INCOME TAXES
The
Company is subject to taxation in the United States and California. The benefit from income taxes for the years ended December
31, 2020 and 2019 are summarized below:
|
|
2020
|
|
|
2019
|
|
Current:
|
|
|
|
|
|
|
Federal
|
|
$
|
-
|
|
|
$
|
-
|
|
State
|
|
|
-
|
|
|
|
-
|
|
Total
current
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Deferred:
|
|
|
|
|
|
|
|
|
Federal
|
|
|
5,184
|
|
|
|
(29,833
|
)
|
State
|
|
|
-
|
|
|
|
-
|
|
Change
in valuation allowance
|
|
|
(55,952
|
)
|
|
|
29,833
|
|
Total
deferred
|
|
|
(50,768
|
)
|
|
|
-
|
|
Income
tax provision (benefit)
|
|
$
|
(50,768
|
)
|
|
$
|
-
|
|
At
December 31, 2020, the Company had federal net operating loss carry forwards of approximately $210,000 which may
be offset against future taxable income through 2037. No net deferred tax assets are recorded at December 31, 2020 or 2019, as
all deferred tax assets and liabilities have been fully offset by a valuation allowance due to the uncertainty of future utilization.
At
December 31, 2020 and 2019, deferred tax assets (liabilities) consist of the following:
|
|
2020
|
|
|
2019
|
|
|
|
|
|
|
|
|
Net
operating loss carry-forwards
|
|
$
|
50,768
|
|
|
$
|
55,952
|
|
Other
|
|
|
-
|
|
|
|
-
|
|
Total
deferred tax assets
|
|
|
50,768
|
|
|
|
55,952
|
|
Less:
valuation allowance
|
|
|
-
|
|
|
|
(55,952
|
)
|
|
|
|
|
|
|
|
|
|
Net
deferred tax assets
|
|
$
|
50,768
|
|
|
$
|
-
|
|
During the year ended December
31, 2020, the Company eliminated its valuation allowance due to the Sellavir acquisition and projected profit, where the Company
expects to utilize its net operations carryforwards. The change in valuation allowance for the year ended December 31, 2020 of
approximately $56,000 was to account for the elimination of the valuation allowance. The change in the valuation allowance
during the year ended December 31, 2019 was an approximate $30,000 increase, respectively, and a full valuation allowance
had been recorded. The ultimate realization of deferred tax assets and liabilities is dependent upon the generation
of future taxable income during periods in which those temporary differences and carryforwards become deductible or are utilized.
A
reconciliation of the statutory federal income tax rate for the year ended December 31, 2020 and 2019 to the effective tax rate
is as follows:
|
|
2020
|
|
|
2019
|
|
Expected
federal tax
|
|
|
21.00
|
%
|
|
|
21.00
|
%
|
Change in Valuation
allowance
|
|
|
(227.00
|
)%
|
|
|
(21.00
|
)%
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
(206.00
|
)%
|
|
|
-
|
%
|
The
Company follows ASC 740-10, Uncertainty in Income Taxes. The Company recognizes interest and penalties associated with uncertain
tax positions as a component of income tax expense. The Company does not have any unrecognized tax benefits or a liability for
uncertain tax positions at December 31, 2020 and 2019. The Company does not expect to have any unrecognized tax benefits within
the next twelve months. The Company recognizes accrued interest and penalties associated with uncertain tax positions, if any,
as part of income tax expense. There were no tax related interest and penalties recorded for 2020 and 2019. Since the Company
incurred net operating losses in every tax year since inception, all of its income tax returns are subject to examination and
adjustments by the IRS for at least three years following the year in which the tax attributes are utilized.
NOTE
4–DUE FROM OFFICER
Sellavir
had advanced its Officer and sole Shareholder $332,553 during 2019 and 2020 and was included in the Sellavir acquisition discussed
in Note 7. The full amount was paid to the Company in March 2021.
NOTE
5–PROPERTY AND EQUIPMENT
Property and Equipment at December 31,
2020 and 2019 consisted of:
|
|
2020
|
|
|
2019
|
|
Computer Equipment
|
|
$
|
4,005
|
|
|
$
|
-
|
|
Accumulated Depreciation
|
|
|
(35
|
)
|
|
|
-
|
|
Net Property & Equipment
|
|
$
|
3,970
|
|
|
$
|
-
|
|
The
Company recognized $35 in depreciation expense for the year ended December 31, 2020.
NOTE
6–STOCKHOLDERS’ EQUITY
The
Company was formed with one class of no par value common stock and was authorized to issue 50,000,000 common shares, as amended.
Voting rights are not cumulative and, therefore, the holders of more than 50% of the common stock could, if they chose to do so,
elect all of the directors of the Company.
During
2020, the Company issued 333,333 shares of common stock in connection with the Sellavir acquisition discussed in Note 7.
NOTE
7–SELLAVIR, INC. ACQUISITION
During
December 2020, the Company acquired the common controlled entity, Sellavir, Inc. Sellavir is a video analytics company whose platform
empowers organizations to decode videos to develop creative marketing strategies and analysis through advanced and proprietary
technologies. Sellavir was owned 100% by Quarta-Rad’s majority shareholder. 333,333 shares of common stock in Quarta-Rad
were exchanged for 100% of the outstanding shares of Sellavir.
Under
an acquisition of common control, the purchase is recorded at historical cost. The fair value of the common stock issued was approximately
$170,000. The excess carry-over basis of the net assets acquired was treated as a capital contribution and included in additional
paid-in capital.
The balance sheet of Sellavir on date
of acquistion consisted of:
Assets:
|
|
|
|
Cash
|
|
$
|
29,665
|
|
Due from Officer
|
|
|
332,553
|
|
Fixed Assets, net
|
|
|
4,005
|
|
Total Assets
|
|
$
|
366,223
|
|
|
|
|
|
|
Liabilities & Equity:
|
|
|
|
|
Accrued Expenses
|
|
$
|
78,660
|
|
Deferred Revenue
|
|
|
15,000
|
|
Net Equity
|
|
$
|
272,563
|
|
Pro-forma
Statement of Operations including full year Sellavir (unaudited):
|
|
|
For
the year ended December 31, 2020
|
|
|
|
|
|
|
Sales
-Quarta Rad, Inc., net
|
|
$
|
843,015
|
|
Sales
- Sellavir, Inc., net
|
|
|
440,000
|
|
|
|
|
|
|
Total
sales, net
|
|
|
1,283,015
|
|
|
|
|
|
|
Cost
of goods sold - Quarta Rad, Inc.
|
|
|
645,140
|
|
|
|
|
|
|
Gross
profit
|
|
|
637,875
|
|
|
|
|
|
|
Expenses:
|
|
|
|
|
General
& administrative
|
|
|
16,684
|
|
Advertising
|
|
|
63,122
|
|
Professional
and consulting fees
|
|
|
196,906
|
|
Operating
Expenses
|
|
|
276,712
|
|
|
|
|
|
|
Net
income from operations
|
|
|
361,163
|
|
|
|
|
|
|
Other
expense - income taxes
|
|
|
19,892
|
|
|
|
|
|
|
Net
income
|
|
$
|
341,271
|
|
|
|
|
|
|
Loss
per share - basic and diluted
|
|
$
|
0.02
|
|
|
|
|
|
|
Weighted
average shares - basic and diluted
|
|
|
15,659,483
|
|
NOTE
8–RELATED PARTY TRANSACTIONS
The
Company sells radiation monitors and to date has purchased all of it inventory from a company in Russia, which is owned by the
Company’s minority shareholder. Total inventory purchased was $584,550 and $518,750 for 2020 and 2019, respectively. The
Company owes the Russian affiliate $126,390 and such amount is included in related party payables in the accompanying balance
sheet at December 31, 2020 and 2019. The related payable balance is related to a research and development contract entered into
by the parties noted below and inventory purchases.
During
July 2017 the Company entered into an agreement with the Russian Affiliate to develop and update software for a new device for
$180,000. The development contract goes through December 31, 2019. The amount due in connection with this agreement as of December
31, 2020 is $126,390.
Since
inception, the Company has not compensated its CEO, who is the majority shareholder, and, as of December 31, 2020 and 2019, is
due $40,935 and $21,918, respectively, for expenses paid on behalf of the Company.
During
the period December 16, 2020 to December 31, 2020, the Company, through Sellavir, Inc. recognized $15,000 in services to a company
owned by our majority shareholder.
NOTE
9– COMMITMENTS AND CONTINGENCIES
Contingencies
The
Company is currently undergoing a multi-year VAT tax examination by certain European tax authorities. As of December 31, 2020,
the outcome of these examinations is uncertain and the Company is disputing any amounts due. The estimated liabilities on the
VAT tax exposure could anywhere from $0 to $125,000 based on estimates and information provided to management. The Company believes
its exposure is limited to $100,000, which was accrued in 2019. The Company paid $41,822 during 2020 towards the estimated liability,
a remainder of $58,178 is included in accounts payable and accrued expenses, as of December 31, 2020. Actual results
from this matter could differ from this estimate.
Legal
In
the normal course of business, the Company may become involved in various legal proceedings. The Company knows of no pending or
threatened legal proceeding to which the Company is or will be a party that, if successful, might result in material adverse change
in the Company’s business, properties or financial condition.
NOTE
10–SUBSEQUENT EVENTS
The
Company has performed an evaluation of events occurring subsequent to December 31, 2020 through April 15, 2021. Based on
its evaluation, other than the note below, there is nothing to be disclosed herein.
The
Due from officer amount of $332,553 was repaid in March 2021.
NOTE
11 - COVID-19
On
January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain
of coronavirus (the “COVID-19 outbreak”) and the risks to the international community as the virus spreads globally
beyond its point of origin. In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase
in exposure globally.
The
full impact of the COVID-19 outbreak continues to evolve as of the date of this report. Management is actively monitoring the
global situation on its financial condition, liquidity, operations, suppliers, industry, and workforce. Given the daily evolution
of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19
outbreak on its results of operations, financial condition, or liquidity. However, if the pandemic continues, it may have an adverse
effect on the Company’s results of future operations, financial position, and liquidity.
The
uncertainty as to the future impact on the Company of the recent COVID-19 outbreak has been considered as part of the Company’s
adoption of the going concern basis. Thus far, we have not observed a material impact on our sales during 2020 and early 2021.